Literature DB >> 7871610

[Implementing ambulatory prevention of thrombosis with low molecular weight heparin in plaster immobilization of the lower extremity].

H J Kock1, K P Schmit-Neuerburg, J Hanke, A Terwort, G Rudofsky, H Hirche.   

Abstract

Plaster cast immobilisation following trauma is a major risk factor for the development of deep vein thrombosis. In our controlled, randomized and prospective study in patients with minor injuries the incidence of deep vein thrombosis was 4.3% in conservatively treated outpatients with plaster cast immobilisation of the leg (n = 163 control group without prophylaxis). By application of low molecular weight heparin once daily the number of deep vein thrombosis in the prophylaxis group (n = 176) was reduced to 0% (p = 0.006). No severe side effects of low molecular weight heparin were observed. Subcutaneous injections were self-applicated by 89% of males and 72% of females. We conclude that thromboprophylaxis with low molecular weight heparin once daily is effective to reduce the risk of deep vein thrombosis in outpatients with plaster cast immobilisation of the leg.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7871610     DOI: 10.1007/bf02588744

Source DB:  PubMed          Journal:  Unfallchirurgie        ISSN: 0340-2649


  27 in total

Review 1.  [Prevention of thromboembolism in trauma surgery and orthopedics].

Authors:  S Haas; P Haas
Journal:  Chirurg       Date:  1992-04       Impact factor: 0.955

2.  [Different effectiveness of two preparations of low molecular weight heparin in patients with elective hip joint replacement].

Authors:  U Weber; K Koppenhagen; H Mälzer; M Matthes
Journal:  Langenbecks Arch Chir       Date:  1991

Review 3.  [The therapy of heparin-associated thrombocytopenia].

Authors:  A Greinacher; C Mueller-Eckhardt
Journal:  Dtsch Med Wochenschr       Date:  1991-09-27       Impact factor: 0.628

Review 4.  [The diagnosis of heparin-associated thrombocytopenia].

Authors:  A Greinacher; C Mueller-Eckhardt
Journal:  Dtsch Med Wochenschr       Date:  1991-09-27       Impact factor: 0.628

5.  The hazards of aspirin plus heparin.

Authors:  H S Yett; J J Skillman; E W Salzman
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

6.  A multiple testing procedure for clinical trials.

Authors:  P C O'Brien; T R Fleming
Journal:  Biometrics       Date:  1979-09       Impact factor: 2.571

7.  [Ambulatory long-term prevention of thromboembolism with low-molecular weight heparin].

Authors:  J Harenberg; G Leber; J Augustin; R Raedsch; F Schwarz; A Stiehl; R Zimmermann
Journal:  Klin Wochenschr       Date:  1987-04-01

8.  [Forensic aspects of deep venous thrombosis of the leg].

Authors:  G Carstensen
Journal:  Orthopade       Date:  1993-04       Impact factor: 1.087

9.  [Prevention of thrombosis in ambulatory patients].

Authors:  H Reilmann; A M Weinberg; E E Förster; B Happe
Journal:  Orthopade       Date:  1993-04       Impact factor: 1.087

Review 10.  [Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin].

Authors:  G Pindur; M Köhler; M Heiden; C Leipnitz; K H Rupp; E Wenzel
Journal:  Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir       Date:  1990
View more
  4 in total

Review 1.  [Heparin-induced thrombocytopenia type II (HIT II) : A medical-economic view].

Authors:  R Riedel; A Schmieder; A Koster; S Kim; G Baumgarten; J C Schewe
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-12-22       Impact factor: 0.840

Review 2.  Low molecular weight heparin for prevention of venous thromboembolism in patients with lower-limb immobilization.

Authors:  Aniek Ag Zee; Kelly van Lieshout; Maaike van der Heide; Loes Janssen; Heinrich Mj Janzing
Journal:  Cochrane Database Syst Rev       Date:  2017-08-06

3.  [Compliance of patients undergoing thromboprophylaxis with enoxaparin: the COMFORT study].

Authors:  S Rübenacker; J Kaiser; M Guschmann
Journal:  Chirurg       Date:  2013-03       Impact factor: 0.955

4.  Insufficient Evidence for Routine Use of Thromboprophylaxis in Ambulatory Patients with an Isolated Lower Leg Injury Requiring Immobilization: Results of a Meta-Analysis.

Authors:  Roderik Metz; Egbert-Jan M M Verleisdonk; Geert J M G van der Heijden
Journal:  Eur J Trauma Emerg Surg       Date:  2008-12-08       Impact factor: 3.693

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.